DAVID W GOLDING Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID W GOLDING.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID W GOLDING. DAVID W GOLDING is EVP-Specialty Pharmacy in CAREMARK RX INC ($CMX) and SVP-Specialty Pharmacy in CAREMARK RX INC ($CMX) and Director in BioScrip, Inc. ($MIMS).
Latest Insider Trading Transactions of DAVID W GOLDING
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 24 2020 | MIMS | Option Care Health ... | GOLDING DAVID W | Director | Grant | A | 0.00 | 14,978 | 0 | 70,813 | 55.8 K to 70.8 K (+26.83 %) |
| Dec 11 2019 | MIMS | Option Care Health ... | GOLDING DAVID W | Director | Grant | A | 0.00 | 60,448 | 0 | 223,343 | 162.9 K to 223.3 K (+37.11 %) |
| Jun 05 2019 | MIMS | BioScrip, Inc. | GOLDING DAVID W | Director | Option Exercise | A | 0.00 | 18,905 | 0 | 18,905 | |
| May 07 2018 | MIMS | BioScrip, Inc. | GOLDING DAVID W | Director | Grant | A | 0.00 | 43,726 | 0 | 162,895 | 119.2 K to 162.9 K (+36.69 %) |
| May 04 2017 | MIMS | BioScrip, Inc. | GOLDING DAVID W | Director | Grant | A | 0.00 | 49,669 | 0 | 119,169 | 69.5 K to 119.2 K (+71.47 %) |
| Jul 08 2016 | MIMS | BioScrip, Inc. | GOLDING DAVID W | Director | Grant | A | 0.00 | 7,000 | 0 | 69,500 | 62.5 K to 69.5 K (+11.20 %) |
| Jul 06 2016 | MIMS | BioScrip, Inc. | GOLDING DAVID W | Director | Grant | A | 0.00 | 20,000 | 0 | 62,500 | 42.5 K to 62.5 K (+47.06 %) |
| Jun 20 2016 | MIMS | BioScrip, Inc. | GOLDING DAVID W | Director | Buy | P | 2.48 | 12,500 | 30,978 | 42,500 | 30 K to 42.5 K (+41.67 %) |
| Jun 02 2016 | MIMS | BioScrip, Inc. | GOLDING DAVID W | Director | Option Exercise | M | 0.00 | 10,000 | 0 | 0 | |
| Jun 02 2016 | MIMS | BioScrip, Inc. | GOLDING DAVID W | Director | Sell | D | 2.70 | 10,000 | 27,000 | 30,000 | 40 K to 30 K (-25.00 %) |
| Jun 02 2016 | MIMS | BioScrip, Inc. | GOLDING DAVID W | Director | Buy | M | 0.00 | 10,000 | 0 | 40,000 | 30 K to 40 K (+33.33 %) |
| Aug 19 2015 | MIMS | BioScrip, Inc. | GOLDING DAVID W | Director | Buy | P | 1.54 | 20,000 | 30,820 | 30,000 | 10 K to 30 K (+200.00 %) |
| May 22 2015 | MIMS | BioScrip, Inc. | GOLDING DAVID W | Director | Option Exercise | A | 0.00 | 10,000 | 0 | 10,000 | |
| May 21 2015 | MIMS | BioScrip, Inc. | GOLDING DAVID W | Director | Buy | P | 4.02 | 10,000 | 40,159 | 10,000 | 0 to 10 K |
| Mar 26 2007 | CMX | CAREMARK RX INC | GOLDING DAVID W | EVP-Specialty Pharm ... | Option Exercise | D | 50.84 | 75,000 | 3,813,000 | 0 | |
| Mar 26 2007 | CMX | CAREMARK RX INC | GOLDING DAVID W | EVP-Specialty Pharm ... | Option Exercise | D | 37.92 | 150,000 | 5,688,000 | 0 | |
| Mar 26 2007 | CMX | CAREMARK RX INC | GOLDING DAVID W | EVP-Specialty Pharm ... | Option Exercise | D | 32.03 | 100,000 | 3,203,000 | 0 | |
| Mar 26 2007 | CMX | CAREMARK RX INC | GOLDING DAVID W | EVP-Specialty Pharm ... | Option Exercise | D | 18.35 | 25,000 | 458,750 | 0 | |
| Mar 26 2007 | CMX | CAREMARK RX INC | GOLDING DAVID W | EVP-Specialty Pharm ... | Sell | D | 0.00 | 976 | 0 | 0 | 976 to 0 (-100.00 %) |
| Mar 03 2006 | CMX | CAREMARK RX INC | GOLDING DAVID W | EVP-Specialty Pharm ... | Option Exercise | A | 50.84 | 75,000 | 3,813,000 | 75,000 | |
| Nov 15 2005 | CMX | CAREMARK RX INC | GOLDING DAVID W | SVP-Specialty Pharm ... | Option Exercise | M | 15.80 | 20,000 | 316,000 | 0 | |
| Nov 15 2005 | CMX | CAREMARK RX INC | GOLDING DAVID W | SVP-Specialty Pharm ... | Sell | S | 51.01 | 700 | 35,707 | 976 | 1.7 K to 976 (-41.77 %) |
| Nov 15 2005 | CMX | CAREMARK RX INC | GOLDING DAVID W | SVP-Specialty Pharm ... | Sell | S | 51.00 | 19,300 | 984,300 | 1,676 | 21 K to 1.7 K (-92.01 %) |
| Nov 15 2005 | CMX | CAREMARK RX INC | GOLDING DAVID W | SVP-Specialty Pharm ... | Buy | M | 15.80 | 20,000 | 316,000 | 20,976 | 976 to 21 K (+2,049.18 %) |
| Mar 03 2005 | CMX | CAREMARK RX INC | GOLDING DAVID W | SVP-Specialty Pharm ... | Option Exercise | A | 37.92 | 150,000 | 5,688,000 | 150,000 | |
| May 17 2004 | CMX | CAREMARK RX INC | GOLDING DAVID W | SVP-Specialty Pharm ... | Option Exercise | M | 12.25 | 25,000 | 306,250 | 0 | |
| May 17 2004 | CMX | CAREMARK RX INC | GOLDING DAVID W | SVP-Specialty Pharm ... | Option Exercise | M | 14.78 | 1,177 | 17,393 | 0 | |
| May 17 2004 | CMX | CAREMARK RX INC | GOLDING DAVID W | SVP-Specialty Pharm ... | Sell | S | 33.19 | 26,587 | 882,377 | 976 | 27.6 K to 976 (-96.46 %) |
| May 17 2004 | CMX | CAREMARK RX INC | GOLDING DAVID W | SVP-Specialty Pharm ... | Buy | M | 12.25 | 25,000 | 306,250 | 27,563 | 2.6 K to 27.6 K (+975.42 %) |
| May 17 2004 | CMX | CAREMARK RX INC | GOLDING DAVID W | SVP-Specialty Pharm ... | Buy | M | 14.78 | 1,177 | 17,393 | 2,563 | 1.4 K to 2.6 K (+84.92 %) |
| May 12 2004 | CMX | CAREMARK RX INC | GOLDING DAVID W | SVP-Specialty Pharm ... | Option Exercise | A | 32.03 | 100,000 | 3,203,000 | 100,000 |
Page: 1